The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Abstract
Phosphorothioates have found their usefulness in the general area of oligonucleotide therapeutic applications. Initially this modification was introduced into the antisense methodology because of the nuclease resistance of the phosphorothioate linkage in comparison with that of the phosphate linkage. However, as experimental data accumulated, it was detected that this chemical modification also facilitates cellular uptake and bioavailibity in vivo. Thus, today the majority of therapeutic oligonucleotides contain this modification. This review will discuss the historical development of this modification and present some of its chemical properties where they differ from those of the phosphate group. The antisense application will be discussed in the original context with cleavage of the target mRNA, but other target RNAs such as microRNAs and long noncoding RNAs will also be covered. It continues with applications where the target RNA should not be cleaved. A brief presentation of decoy oligonucleotides will be included, as well as some miscellaneous applications. Cellular uptake is a crucial step for oligonucleotides to reach their target and will be briefly reviewed. Lastly, a most surprising recent observation is the presence of phosphorothioate groups in bacterial DNA where functions still remain to be fully determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Broad distribution of ASOs, systemically and in the CNS, has been achieved primarily using phosphorothioate (PS) backbone modifications12.”
From A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system (2019) · cites this paper as [12]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The nature of the chemical bond—1992
Pauling, L. C. (1992) · Journal of Chemical Education · doi:10.1021/ed069p519 · Cited by 13,235
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
A Sequencing Method Based on Real-Time Pyrophosphate
Ronaghi, M., Uhlén, M., & Nyrén, P. (1998) · Science · doi:10.1126/science.281.5375.363 · Cited by 1,630
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Bennett, C. F., & Swayze, E. E. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,431
Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution
Ulitsky, I., Shkumatava, A., Jan, C. H., Sive, H. L., & Bartel, D. P. (2011) · Cell · doi:10.1016/j.cell.2011.11.055 · Cited by 1,197
A general two-metal-ion mechanism for catalytic RNA
Steitz, T. A., & Steitz, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6498 · Cited by 1,171
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Pearson, R. G. (1966) · Science · doi:10.1126/science.151.3707.172 · Cited by 979
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M., Cromwell, W. C., Lachmann, R., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 934
Eckstein, F. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.002055 · Cited by 849
Self-citationMonia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D. P. C., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 779
Modarresi, F., Faghihi, M. A., López-Toledano, M. A., Fatemi, R. P., Magistri, M., Brothers, S. P., van der Brug, M. P., & Wahlestedt, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2158 · Cited by 683
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse modelPreprint
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 680
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Goemans, N., Tulinius, M., van den Akker, J. T., Burm, B. E. A., Ekhart, P. F., Heuvelmans, N., Holling, T. M., Janson, A. A. M., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 675
Prakash, T. P., Graham, M., Yu, J., Carty, R., Low, A., Chappell, A., Schmidt, K., Zhao, C., Aghajan, M., Murray, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku531 · Cited by 588
Valouev, A., Ichikawa, J. K., Tonthat, T., Stuart, J., Ranade, S., Peckham, H. E., Zeng, K., Malek, J. A., Costa, G. L., McKernan, K. J., et al. (2008) · Genome Research · doi:10.1101/gr.076463.108 · Cited by 580
Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M. S., Cohen, J. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7706 · Cited by 533
Specificity, duplex degradation and subcellular localization of antagomirs
Krützfeldt, J., Kuwajima, S., Braich, R. S., Rajeev, K. G., Pena, J., Tuschl, T., Manoharan, M., & Stoffel, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm024 · Cited by 462
Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
Walder, R. Y., & Walder, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5011 · Cited by 453
Regulation of Gene Expression with Double-Stranded Phosphorothioate Oligonucleotides
Bielinska, A. U., Shivdasani, R. A., Zhang, L., & Nabel, G. J. (1990) · Science · doi:10.1126/science.2237444 · Cited by 372
Stein, C. A., Hansen, J. B., Lai, J., Wu, S., Voskresenskiy, A., H⊘g, A., Worm, J., Hedtjärn, M., Souleimanian, N., Miller, P., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp841 · Cited by 360
RNA catalyses nuclear pre-mRNA splicing
Fica, S. M., Tuttle, N., Novak, T., Li, N., Lu, J., Koodathingal, P., Dai, Q., Staley, J. P., & Piccirilli, J. A. (2013) · Nature · doi:10.1038/nature12734 · Cited by 348
A semisynthetic epitope for kinase substrates
Allen, J. J., Li, M., Brinkworth, C. S., Paulson, J., Wang, D., Hübner, A., Chou, W.-H., Davis, R. J., Burlingame, A. L., Messing, R. O., et al. (2007) · Nature Methods · doi:10.1038/nmeth1048 · Cited by 330
MODIFIED OLIGONUCLEOTIDES: Synthesis and Strategy for Users
Verma, S. K., & Eckstein, F. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.99 · Cited by 315
Self-citationPecoraro, V. L., Hermes, J. D., & Cleland, W. W. (1984) · Biochemistry · doi:10.1021/bi00317a026 · Cited by 291
Agrawal, S., Goodchild, J., Civeira, M. P., Thornton, A., Sarin, P. S., & Zamecnik, P. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7079 · Cited by 291
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H. M., Manoharan, M., & Levin, A. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 289
Bond Order and Charge Localization in Nucleoside Phosphorothioates
Frey, P. A., & Sammons, R. D. (1985) · Science · doi:10.1126/science.2984773 · Cited by 281
Koller, E., Vincent, T. M., Chappell, A., De, S., Manoharan, M., & Bennett, C. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr089 · Cited by 281
Stec, W. J., Zon, G., & Egan, W. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00332a054 · Cited by 278
Yu, D., Pendergraff, H. M., Liu, J., Kordasiewicz, H. B., Cleveland, D. W., Swayze, E. E., Lima, W. F., Crooke, S. T., Prakash, T. P., & Corey, D. R. (2012) · Cell · doi:10.1016/j.cell.2012.08.002 · Cited by 277
The Role of Environmental Carcinogens, Viruses, and Genetic
Powers, A. A., & Carbone, M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.4 · Cited by 276
Phosphorothioation of DNA in bacteria by dnd genes
Wang, L., Chen, S., Xu, T., Taghizadeh, K., Wishnok, J. S., Zhou, X., You, D., Deng, Z., & Dedon, P. C. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.39 · Cited by 274
Matsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong‐Staal, F., Cohen, J. S., & Broder, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4244 · Cited by 263
Single-Stranded siRNAs Activate RNAi in Animals
Lima, W. F., Prakash, T. P., Murray, H. M., Kinberger, G. A., Li, W., Chappell, A. E., Li, C., Murray, S., Gaus, H. J., Seth, P. P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.014 · Cited by 260
The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA
Taylor, J. W., SCHMIDT, W. A., Cosstick, R., Okruszek, A., & Eckstein, F. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.24.8749 · Cited by 245
Self-citationPerry, C. M., & Balfour, J. A. B. (1999) · Drugs · doi:10.2165/00003495-199957030-00010 · Cited by 243
DNA and RNA Sequence Determination Based on Phosphorothioate Chemistry
Gish, G. D., & Eckstein, F. (1988) · Science · doi:10.1126/science.2453926 · Cited by 232
Self-citationLi, N., Frederiksen, J. K., & Piccirilli, J. A. (2011) · Accounts of Chemical Research · doi:10.1021/ar200131t · Cited by 225
Brautigam, C. A., & Steitz, T. A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1586 · Cited by 205
Adenosine 5′-0(3-thiotriphosphate) in the control of phosphorytase activity
Gratecos, D., & Fischer, E. H. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(74)80237-8 · Cited by 190
CpG Still Rocks! Update on an Accidental Drug
Krieg, A. Μ. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0340 · Cited by 184
Thiophosphate analogs of nucleoside di- and triphosphates
Goody, R. S., & Eckstein, F. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00752a042 · Cited by 181
Self-citation(2007) · CRC Press eBooks · doi:10.1201/9780849387951 · Cited by 181
Furdon, P. J., Domiński, Z., & Kole, R. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.22.9193 · Cited by 178
Burgers, P., & Eckstein, F. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50258-1 · Cited by 176
Self-citationMapping the active site of ribonuclease P RNA using a substrate containing a photoaffinity agent.
Burgin, A. B., & Pace, N. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07633.x · Cited by 175
Burgers, P., & Eckstein, F. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4798 · Cited by 169
Self-citationPotter, B. V. L., Connolly, B. A., & Eckstein, F. (1983) · Biochemistry · doi:10.1021/bi00275a008 · Cited by 166
Self-citationConnolly, B. A., Potter, B. V. L., Eckstein, F., Pingoud, A. M., & Grotjahn, L. (1984) · Biochemistry · doi:10.1021/bi00310a010 · Cited by 159
Self-citationJaffe, E. K., & Cohn, M. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34617-3 · Cited by 149
Inhibition of deoxyribonucleases by phosphorothioate groups in oligodeoxyribonucleotides
Spitzer, S. G., & Eckstein, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.24.11691 · Cited by 143
Self-citationGeometry of the First Step in the Action of Ribonuclease-A
Usher, D. A., Erenrich, E. S., & Eckstein, F. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.1.115 · Cited by 140
Self-citationInterferon Induction Increased through Chemical Modification of a Synthetic Polyribonucleotide
Clercq, E. D., Eckstein, F., & Merigan, T. C. (1969) · Science · doi:10.1126/science.165.3898.1137 · Cited by 135
Self-citationJuliano, R. L., Ming, X., Carver, K. A., & Laing, B. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0463 · Cited by 135
A novel host-specific restriction system associated with DNA backbone S-modification in Salmonella
Xu, T., Yao, F., Zhou, X., Deng, Z., & You, D. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq610 · Cited by 134
Absolute Stereochemistry of the Second Step of Ribonuclease Action
Usher, D. A., Richardson, D. I., & Eckstein, F. (1970) · Nature · doi:10.1038/228663a0 · Cited by 132
Self-citationGriffiths, A. D., POTTER, B. V. L., & Eperon, I. C. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.10.4145 · Cited by 127
Hung, G., Xiao, X., Peralta, R. Q., Bhattacharjee, G., Murray, S., Norris, D., Guo, S., & Monia, B. P. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0443 · Cited by 126
Oka, N., Yamamoto, M., Sato, T., & Wada, T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805780u · Cited by 123
Chiral phosphorothioate analogues of B-DNA
Cruse, W. B. T., Salisbury, S. A., Brown, T., Cosstick, R., Eckstein, F., & Kennard, O. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90035-5 · Cited by 123
Self-citationStec, W. J., Karwowski, B. T., Boczkowska, M., Guga, P., Koziołkiewicz, M., Sochacki, M., Wieczorek, M. W., & Błaszczyk, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973801j · Cited by 122
Skerra, A. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.14.3551 · Cited by 118
Eckstein, F. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00970a054 · Cited by 116
Self-citationKoziołkiewicz, M., Krakowiak, A., Kwinkowski, M., Boczkowska, M., & Stec, W. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5000 · Cited by 111
Chemical Modification Study of Antisense Gapmers
Stanton, R. V., Sciabola, S., Salatto, C. T., Weng, Y., Moshinsky, D., Little, J., Walters, E., Kreeger, J. M., DiMattia, D. A., Chen, T. X., et al. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0366 · Cited by 110
Genomic mapping of phosphorothioates reveals partial modification of short consensus sequences
Cao, B., Chen, C., DeMott, M. S., Cheng, Q., Clark, T. A., Xiong, X., Zheng, X., Butty, V. L., Levine, S. S., Yuan, G., et al. (2014) · Nature Communications · doi:10.1038/ncomms4951 · Cited by 107
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
Zhang, Q., Hossain, D. M. S., Nechaev, S., Kozłowska, A. K., Zhang, W., Liu, Y., Kowolik, C. M., Swiderski, P. M., Rossi, J. J., Forman, S. J., et al. (2013) · Blood · doi:10.1182/blood-2012-07-442590 · Cited by 107
Strobel, S. A., & Shetty, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2903 · Cited by 107
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
Rigo, F., Hua, Y., Chun, S. J., Prakash, T. P., Krainer, A. R., & Bennett, C. F. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.939 · Cited by 104
A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications
Järver, P., O’Donovan, L., & Gait, M. J. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0454 · Cited by 102
Deoxynucleoside [1-thio]triphosphates prevent proofreading during in vitro DNA synthesis.
Kunkel, T. A., Eckstein, F., Mildvan, A. S., Koplitz, R. M., & Loeb, L. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6734 · Cited by 102
Self-citationSaenger, W., & Eckstein, F. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00718a038 · Cited by 98
Self-citationMovement of the Guide Sequence During RNA Catalysis by a Group I Ribozyme
Wang, J., Downs, W. D., & Cech, T. R. (1993) · Science · doi:10.1126/science.7682726 · Cited by 97
Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
Porensky, P. N., & Burghes, A. H. M. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.225 · Cited by 89
Boczkowska, M., Guga, P., & Stec, W. J. (2002) · Biochemistry · doi:10.1021/bi026225z · Cited by 88
Romaniuk, P. J., & Eckstein, F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34435-1 · Cited by 86
Self-citationPhosphorothioate DNA as an antioxidant in bacteria
Xie, X., Liang, J., Pu, T., Xu, F., Yao, F., Yang, Y., Zhao, Y., You, D., Zhou, X., Deng, Z., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks650 · Cited by 81
Nakamaye, K. L., Gish, G. D., Eckstein, F., & Vosberg, H.-P. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.21.9947 · Cited by 79
Self-citationSouleimanian, N. E., Deleavey, G. F., Soifer, H. S., Wang, S., Tiemann, K., Damha, M. J., & Stein, C. A. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.35 · Cited by 71
Development of Therapeutic Splice-Switching Oligonucleotides
Disterer, P., Kryczka, A., Liu, Y., Badi, Y. E., Wong, J. J., Owen, J. S., & Khoo, B. C. E. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.234 · Cited by 71
Lok, C., Viazovkina, E., Min, K., Nagy, E., Wilds, C. J., Damha, M. J., & Parniak, M. A. (2002) · Biochemistry · doi:10.1021/bi0115075 · Cited by 70
Kandimalla, E. R., Bhagat, L., Wang, D., Yu, D. S., Sullivan, T., Monica, N. L., & Agrawal, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt078 · Cited by 69
Oligonucleotide N3′→P5′ Phosphoramidates and Thio‐Phoshoramidates as Potential Therapeutic Agents
Gryaznov, S. M. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900187 · Cited by 68
Synthesis of dinucleoside monophosphorothioates via addition of sulphur to phosphite triesters.
Burgers, P., & Eckstein, F. (1978) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)95072-5 · Cited by 62
Self-citationFluorescent labelling of tRNA and oligodeoxynucleotides using T4 RNA ligase
Cosstick, R., McLaughlin, L. W., & Eckstein, F. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.4.1791 · Cited by 61
Self-citationZhang, Y., Hollfelder, F., Gordon, S. J., Chen, L., Keng, Y., Wu, L., Herschlag, D., & Zhang, Z. (1999) · Biochemistry · doi:10.1021/bi990836i · Cited by 59
Jirka, S. M. G., Heemskerk, H., Winter, C. L. T.-D., Muilwijk, D., Pang, K. H., de Visser, P. C., Janson, A. A. M., Karnaoukh, T. G., Vermue, R., Hoen, P. A. C. ’., et al. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0448 · Cited by 59
Bartlett, P. A., & Eckstein, F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34212-1 · Cited by 59
Self-citationThe antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo
Clercq, E. D., Eckstein, F., Sternbach, H., & Merigan, T. C. (1970) · Virology · doi:10.1016/0042-6822(70)90285-0 · Cited by 57
Self-citationSulfur does not form double bonds in phosphorothioate anions
Liang, C., & Allen, L. C. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00255a034 · Cited by 55
Stereochemical course of DNA hydrolysis by nuclease S1.
Potter, B. V. L., Romaniuk, P. J., & Eckstein, F. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33051-5 · Cited by 54
Self-citationPhosphorothioate-containing RNAs show mRNA activity in the prokaryotic translation systemsin vitro
Ueda, T., Tohda, H., Chikazumi, N., Eckstein, F., & Watanabe, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.3.547 · Cited by 52
Self-citationP-Chirality-Dependent Immune Activation by Phosphorothioate CpG Oligodeoxynucleotides
Krieg, A. Μ., Guga, P., & Stec, W. J. (2003) · Oligonucleotides · doi:10.1089/154545703322860807 · Cited by 51
Cao, B., Cheng, Q., Gu, C., Yao, F., DeMott, M. S., Zheng, X., Deng, Z., Dedon, P. C., & You, D. (2014) · Molecular Microbiology · doi:10.1111/mmi.12692 · Cited by 49
Stec, W. J., Cierniewski, C. S., Okruszek, A., Kobylańska, A., Pawłowska, Z., Koziołkiewicz, M., Pluskota, E., Maciaszek, A. D., Rębowska, B., & Stasiak, M. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.567 · Cited by 45
Liu, J., Yu, D., Aiba, Y., Pendergraff, H. M., Swayze, E. E., Lima, W. F., Hu, J., Prakash, T. P., & Corey, D. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt693 · Cited by 42
Musier‐Forsyth, K., & SCHIMMEL, P. R. (1994) · Biochemistry · doi:10.1021/bi00169a019 · Cited by 42
A Polyribonucleotide Containing Alternating → P = O and → P = S Linkages
Matzura, H., & Eckstein, F. (1968) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1967.tb19551.x · Cited by 41
Self-citationMetal-ion rescue revisited: Biochemical detection of site-bound metal ions important for RNA folding
Frederiksen, J. K., Li, N., Das, R., Herschlag, D., & Piccirilli, J. A. (2012) · RNA · doi:10.1261/rna.028738.111 · Cited by 40
Incorporation of phosphorothioate groups into fd and φX174 DNA
Vosberg, H.-P., & Eckstein, F. (1977) · Biochemistry · doi:10.1021/bi00635a020 · Cited by 38
Self-citationAllele-Selective Inhibition of Mutant Atrophin-1 Expression by Duplex and Single-Stranded RNAs
Hu, J., Liu, J., Jayaprakash, K. N., Lackey, J. G., Kuchimanchi, S., Rajeev, K. G., Manoharan, M., Swayze, E. E., Lima, W. F., Prakash, T. P., et al. (2014) · Biochemistry · doi:10.1021/bi500610r · Cited by 35
Target mRNA inhibition by oligonucleotide drugs in man
Lightfoot, H. L., & Hall, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks861 · Cited by 34
Effect of ion pairing on bond order and charge localization in alkyl phosphorothioates
Baraniak, J., & Frey, P. A. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00220a067 · Cited by 34
Uridin‐2′.3′‐O.O‐cyclothiophosphat
Eckstein, F., & Gindl, H. (1968) · Chemische Berichte · doi:10.1002/cber.19681010518 · Cited by 33
Self-citationFomiversen Sodium Approved to Treat CMV Retinitis
Piascik, P. (1999) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30428-4 · Cited by 32
Phosphorus-oxygen bond order in adenosine 5'-O-phosphorothioate dianion
Iyengar, R., Eckstein, F., & Frey, P. A. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00338a059 · Cited by 31
Self-citationThiol-ene Enabled Detection of Thiophosphorylated Kinase Substrates
Garber, K. C. A., & Carlson, E. E. (2013) · ACS Chemical Biology · doi:10.1021/cb400184v · Cited by 27
Hiriyanna, K. T., Baedke, D. S., Baek, K., Forney, B. A., Kordiyak, G. J., & Ingebritsen, T. S. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1545 · Cited by 26
Polyribonucleotides containing a thiophosphate backbone
Eckstein, F., & Gindl, H. (1969) · FEBS Letters · doi:10.1016/0014-5793(69)80037-2 · Cited by 26
Self-citationModification of Decoy Oligodeoxynucleotides to Achieve the Stability and Therapeutic Efficacy
Osako, M. K., Hironori Nakagami, A., & Morishita, R. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612803531397 · Cited by 25
Stereochemistry of the transesterification step of pancreatic ribonuclease
Eckstein, F., Saenger, W., & Suck, D. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80235-3 · Cited by 25
Self-citationKinase Assay Based on Thiophosphorylation and Biotinylation
Jeong, S., & Nikiforov, T. T. (1999) · BioTechniques · doi:10.2144/99276rr01 · Cited by 23
Site-Specific Derivatization of RNA with Photocrosslinkable Groups
Konarska, M. M. (1999) · Methods · doi:10.1006/meth.1999.0753 · Cited by 22
Lührmann, A., Tschernig, T., von der Leyen, H. E., Hecker, M., Pabst, R., & Wagner, A. H. (2010) · Experimental Lung Research · doi:10.3109/01902140903144138 · Cited by 22
Hu, J., Liu, J., Yu, D., Aiba, Y., Lee, S., Pendergraff, H. M., Boubaker-Vitre, J., Artates, J. W., Lagier‐Tourenne, C., Lima, W. F., et al. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0476 · Cited by 22
Synthesis, Properties and Application of Nucleic Acids Containing Phosphorothiolate Linkages
Cosstick, R., & Gaynor, J. W. (2008) · Current Organic Chemistry · doi:10.2174/138527208783743769 · Cited by 20
Inhibition of restriction endonuclease hydrolysis by phosphorothioate-containing DNA
Sayers, J. R., Olsen, D. B., & Eckstein, F. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.22.9495 · Cited by 19
Self-citationAntisense-Mediated Exon Skipping: Networking to Meet Opportunities and to Overcome Challenges
Aartsma-Rus, A. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.1500 · Cited by 17
Flagged first, then by citations
Research works printed but not linked: 5
- Dias N, and Stein CA. (2002) Antisense oligonucleotides: Basic concepts and mechanisms. Mol Cancer Ther, 1:347–355.
- Juliano RL. (2005). Peptide-oligonucleotide conjugatesfor the delivery of antisense and siRNA. Curr Opin Mel Ther, 7:132–136.
- Manoharan M. (2013). RNAi therapeutics using GalNAc-siRNA conjugate delivery platform: New era of oligonucleotides. Presented at Oligonucleotide Therapeutics Society Ninth Annual Meeting, Naples, Italy, October 6–8, 2013.
- Bhat B, , Neben S, , Tay J, , Liu K, , Chau N, , Hogan D, , MacKenna D, , Gibson N. (2014). RG-101, a GalNAC-conjugated anti-miR employing a unique mechanism of action by targeting host factor microRNA-122 (miR-122), demonstrates potent activity and reduction of HCV in preclinical studies. Hepatology, 58:1377A–1395A.
- Hutchinson CAIII, , Smith HO, , Pfannkoch C, and Venter JC. (2005). Cell-free cloning using φ29 DNA polymerase. Proc Natl Acad Sci (USA), 102:17322–17336.
Cited by
Sorted by citations
Advances in oligonucleotide drug delivery
Roberts, T. C., Langer, R., & Wood, M. J. A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0075-7 · Cited by 2,121
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld, I., Lunstad, B. D., Kaiser, R. J., Wilkens, A. B., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3290 · Cited by 1,090
Metadata
- Authors
- Eckstein, F.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Eckstein, Fritz
- Venue
- Nucleic Acid Therapeutics
- Publisher
- SAGE Publications
- Published
- 2014-12
- Volume
- 24
- Issue
- 6
- Pages
- 374-387
- ISSN
- 2159-3337 (ISSN-L)
- 2159-3345
- OpenAlex
- W2316132657
- Cited by
- 684
- References
- 123
- Citations by year
- 2026: 69 · 2025: 87 · 2024: 86 · 2023: 75 · 2022: 81 · 2021: 69 · 2020: 64 · 2019: 49 · 2018: 39 · 2017: 25 · 2016: 20 · 2015: 20
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nucleic Acid Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- phosphorothioate, oligonucleotide therapeutics, antisense oligonucleotides, nuclease resistance, cellular uptake, bioavailability, microRNA targeting, long non-coding RNA, decoy oligonucleotides, bacterial DNA
- MeSH terms
- Animals, Humans, Protein Binding, Rabbits, Transcription Factors, Oligonucleotides, Antisense, History, 20th Century, Mice, Phosphorothioate Oligonucleotides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review